Fluoroquinolones and Risk of Severe Hypoglycaemia in Sulphonylurea Users
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Diabetes, Obesity & Metabolism
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Fluoroquinolones and the risk of severe hypoglycaemia among sulphonylurea users: Population-based cohort study
Diabetes Obes Metab 2024 May 02;[EPub Ahead of Print], J Dimakos, Y Cui, RW Platt, C Renoux, KB Filion, A DourosFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.